Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pellegrin, I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Saves, M; Morlat, P; Chene, G; Peuchant, E; Pellegrin, I; Bonnet, F; Bernard, N; Lacoste, D; Salamon, R; Beylot, J
      Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

      CLINICAL IMMUNOLOGY
    2. Pellegrin, I; Garrigue, I; Caumont, A; Pellegrin, JL; Merel, P; Schrive, MH; Bonot, P; Fleury, H
      Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to astavudine-containing regimen

      AIDS
    3. Ngo-Giang-Huong, N; Deveau, C; Da Silva, I; Pellegrin, I; Venet, A; Harzic, M; Sinet, M; Delfraissy, JF; Meyer, L; Goujard, C; Rouzioux, C
      Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

      AIDS
    4. Viallard, JF; Pellegrin, I; Mercie, P; Moreau, JF; Pellegrin, JL
      Infectious mononucleosis

      REVUE DE MEDECINE INTERNE
    5. Merel, P; Pellegrin, I; Garrigue, I; Caumont, A; Schrive, MH; Birac, V; Bonot, P; Fleury, H
      Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis

      JOURNAL OF VIROLOGICAL METHODS
    6. Pellegrin, I; Breilh, D; Birac, V; Deneyrolles, M; Mercie, P; Trylesinski, A; Neau, D; Saux, MC; Fleury, HJA; Pellegrin, JL
      Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens

      THERAPEUTIC DRUG MONITORING
    7. Pellegrin, I; Segondy, M; Garrigue, I; Izopet, J; Montes, B; Pellegrin, JL; Reynes, J; Massip, P; Puel, J; Fleury, H
      Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Morlat, P; Marimoutou, C; Dequae-Merchadou, L; Pellegrin, I; Mercie, I; Neau, D; Beylot, J; Dabis, F
      Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Burgard, M; Izopet, J; Dumon, B; Tamalet, C; Descamps, D; Ruffault, A; Vabret, A; Bargues, G; Mouroux, M; Pellegrin, I; Ivanoff, S; Guisthau, O; Calvez, V; Seigneurin, JM; Rouzioux, C
      HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    10. Garrigue, I; Pellegrin, I; Hoen, B; Dumon, B; Harzic, M; Schrive, MH; Sereni, D; Fleury, H
      Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA

      AIDS
    11. Pellegrin, I; Garrigue, I; Ekouevi, D; Couzi, L; Merville, P; Merel, P; Chene, G; Schrive, MH; Trimoulet, P; Lafon, ME; Fleury, H
      New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients

      JOURNAL OF INFECTIOUS DISEASES
    12. Reynes, J; Denisi, R; Massip, P; Izopet, J; Pellegrin, I; Segondy, M
      Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    13. Molina, JM; Cheuc, G; Ferchal, F; Journot, V; Pellegrin, I; Sombardier, MN; Rancinan, C; Cotte, L; Madelaine, I; Debord, T; Decazes, JM
      Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients

      ANTIVIRAL THERAPY
    14. Pellegrin, I; Izopet, J; Reynes, J; Denayrolles, M; Montes, B; Pellegrin, JL; Massip, P; Puel, J; Fleury, H; Segondy, M
      Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy

      AIDS
    15. Pellegrin, I; Garrigue, I; Binquet, C; Chene, G; Neau, D; Bonot, P; Bonnet, F; Fleury, W; Pellegrin, JL
      Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients

      JOURNAL OF CLINICAL MICROBIOLOGY
    16. Mercie, P; Devianne, I; Viallard, JF; Faure, I; Pellegrin, I; Leng, B; Dupon, M; Barbeau, P; Fleury, H; Pellegrin, JL
      Vascular endothelial growth factor (VEGF(165)) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma

      MICROVASCULAR RESEARCH
    17. Molina, JM; Chene, G; Ferchal, F; Journot, V; Pellegrin, I; Sombardier, MN; Rancinan, C; Cotte, L; Madelaine, I; Debord, T; Decazes, JM
      The ALBI trial: A randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus

      JOURNAL OF INFECTIOUS DISEASES
    18. DAVIANNEGARRIGUE I; PELLEGRIN I; DENISI R; DUPON M; RAGNAUD JM; BARBEAU P; BREILH D; LENG B; FLEURY HJA; PELLEGRIN JL
      FOSCARNET DECREASES HIV-1 PLASMA LOAD

      Journal of acquired immune deficiency syndromes and human retrovirology
    19. MARIMOUTOU C; CHENE G; PELLEGRIN I; MOREAU JF; SPIRA R; NEAU D; LACOSTE D; CECCALDI J; MALVY D; DABIS F
      CD4-INFECTED PATIENTS IN BORDEAUX, FRANCE, 1996-1997( LYMPHOCYTE COUNT AND PLASMA HIV RNA LEVELS IN A SURVEY OF 1602 HIV)

      AIDS
    20. CHENE G; BINQUET C; MOREAU JF; NEAU D; PELLEGRIN I; MALVY D; CECCALDI J; LACOSTE D; DABIS F
      CHANGES IN CD4-ACTIVE ANTIRETROVIRAL TREATMENT( CELL COUNT AND THE RISK OF OPPORTUNISTIC INFECTION OR DEATH AFTER HIGHLY)

      AIDS
    21. SEGONDY M; IZOPET J; PELLEGRIN I; MONTES B; DUMON B; PASQUIER C; PEETERS M; FLEURY HJA; PUEL J; REYNES J
      COMPARISON OF THE QUANTIPLEX HIV-1 RNA-2.0 ASSAY WITH THE AMPLICOR HIV-1 MONITOR-1.0 ASSAY FOR QUANTITATION OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA OF PATIENTS RECEIVING STAVUDINE-DIDANOSINE COMBINATION THERAPY

      Journal of clinical microbiology (Print)
    22. DALOD M; HARZIC M; PELLEGRIN I; DUMON B; HOEN B; SERENI D; DESCHEMIN JC; LEVY JP; VENET A; GOMARD E
      EVOLUTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PATIENTS WITH SYMPTOMATIC PRIMARY INFECTION RECEIVING ANTIRETROVIRAL TRIPLE THERAPY

      The Journal of infectious diseases
    23. LAFON ME; DUTRONC H; DUBOIS V; PELLEGRIN I; BARBEAU P; RAGNAUD JM; PELLEGRIN JL; FLEURY HJA
      JC VIRUS REMAINS LATENT IN PERIPHERAL-BLOOD B-LYMPHOCYTES BUT REPLICATES ACTIVELY IN URINE FROM AIDS PATIENTS

      The Journal of infectious diseases
    24. CONSTANS J; GUERIN V; COUCHOURON A; SEIGNEUR M; RYMAN A; BLANN AD; AMIRAL J; AMARA A; PEUCHANT E; MOREAU JF; PELLEGRIN I; PELLEGRIN JL; FLEURY H; LENG B; CONRI C
      AUTOANTIBODIES DIRECTED AGAINST PHOSPHOLIPIDS OR HUMAN BETA(2)-GLYCOPROTEIN-I IN HIV-SEROPOSITIVE PATIENTS - RELATIONSHIP WITH ENDOTHELIAL ACTIVATION AND ANTIMALONIC DIALDEHYDE ANTIBODIES

      European journal of clinical investigation
    25. LEGRAND E; PELLEGRIN I; NEAU D; PELLEGRIN JL; RAGNAUD JM; DUPON M; GUILLEMAIN B; FLEURY HJA
      COURSE OF SPECIFIC T-LYMPHOCYTE CYTOTOXICITY, PLASMA AND CELLULAR VIRAL LOADS, AND NEUTRALIZING ANTIBODY-TITERS IN 17 RECENTLY SEROCONVERTED HIV TYPE 1-INFECTED PATIENTS

      AIDS research and human retroviruses
    26. DUPON M; TRIMOULET P; PELLEGRIN I; RISPAL P; PELLEGRIN JL; RAGNAUD JM; CECCALDI J; AMOURETTI M; LEBAIL B; BIOULACSAGE P; FLEURY HJA; LACUT JY
      SERUM HEPATITIS-C VIRUS (HCV) RNA LEVELS IN PATIENTS COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) DURING COMBINATION THERAPY WITH RECOMBINANT INTERFERON-ALPHA2B (IFN-ALPHA) AND NUCLEOSIDE ANALOGS

      Hepatology
    27. MOOG C; FLEURY HJA; PELLEGRIN I; KIRN A; AUBERTIN AM
      AUTOLOGOUS AND HETEROLOGOUS NEUTRALIZING ANTIBODY-RESPONSES FOLLOWINGINITIAL SEROCONVERSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS

      Journal of virology
    28. PELLEGRIN I; LEGRAND E; NEAU D; BONOT P; MASQUELIER B; PELLEGRIN JL; RAGNAUD JM; BERNARD N; FLEURY HJA
      KINETICS OF APPEARANCE OF NEUTRALIZING ANTIBODIES IN 12 PATIENTS WITHPRIMARY OR RECENT HIV-1 INFECTION AND RELATIONSHIP WITH PLASMA AND CELLULAR VIRAL LOADS

      Journal of acquired immune deficiency syndromes and human retrovirology
    29. CONSTANS J; DELMASBEAUVIEUX RC; SERGEANT C; PEUCHANT E; PELLEGRIN JL; PELLEGRIN I; CLERC M; FLEURY H; SIMONOFF M; LENG B; CONRI C
      ONE-YEAR ANTIOXIDANT SUPPLEMENTATION WITH BETA-CAROTENE OR SELENIUM FOR PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PILOT-STUDY

      Clinical infectious diseases
    30. SAILLOUR F; DUPON M; PELLEGRIN I; COUZIGOU P; DAVIS F
      PREVALENCE OF HCV AND HBV ANTIBODIES IN H IV-INFECTED PATIENTS

      Medecine et maladies infectieuses
    31. PELLEGRIN I; MAUGEIN J; LAPEYRE C; BARBEAU P; LENG B; PELLEGRIN JL
      ACTIVITY OF RIFABUTIN, CLARITHROMYCIN, ETHAMBUTOL, SPARFLOXACIN AND AMIKACIN, ALONE AND IN COMBINATION, AGAINST MYCOBACTERIUM-AVIUM COMPLEXIN HUMAN MACROPHAGES

      Journal of antimicrobial chemotherapy
    32. MASQUELIER B; PELLEGRIN I; RUFFAULT A; RAGNAUD JM; MORLAT P; MICHELET C; DOIGNON F; BITEAU N; FLEURY HJA
      GENOTYPIC EVOLUTION OF HIV-1 ISOLATES FROM PATIENTS AFTER A SWITCH OFTHERAPY FROM ZIDOVUDINE TO DIDANOSINE

      Journal of acquired immune deficiency syndromes and human retrovirology
    33. CONSTANS J; PELLEGRIN JL; SERGEANT C; SIMONOFF M; PELLEGRIN I; FLEURY H; LENG B; CONRI C
      SERUM SELENIUM PREDICTS OUTCOME IN HIV-INFECTION

      Journal of acquired immune deficiency syndromes and human retrovirology
    34. CONSTANS J; PELLEGRIN I; PELLEGRIN JL; PEUCHANT E; SIMONOFF M; SERGEANT C; FLEURY H; CLERC M; LENG B; CONRI C
      PLASMA INTERFERON-ALPHA AND THE WASTING SYNDROME IN PATIENTS INFECTEDWITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    35. LASSEUR C; MAUGEIN J; PELLEGRIN JL; DUPON M; RAGNAUD JM; MORLAT P; PELLEGRIN I; CONSTANS J; MONLUN E; CHENE G; LENG B; LACOSTE D; DABIS F; SALAMON R
      DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) - REPORT OF 100 CASES

      La Revue de medecine interne
    36. CONSTANS J; PEUCHANT E; PELLEGRIN JL; SERGEANT C; HAMON C; DUBOURG L; THOMAS MJ; SIMONOFF M; PELLEGRIN I; BROSSARD G; BARBEAU P; FLEURY H; CLERC M; LENG B; CONRI C
      FATTY-ACIDS AND PLASMA ANTIOXIDANTS IN HIV-POSITIVE PATIENTS - CORRELATION WITH NUTRITIONAL AND IMMUNOLOGICAL STATUS

      Clinical biochemistry
    37. CONSTANS J; CONRI C; PELLEGRIN JL; SERGEANT C; SIMONOFF M; PEUCHANT E; DUBOURG L; THOMAS MJ; PELLEGRIN I; BROSSARD G; BARBEAU P; AMARA A; GEFFARD M; CLERC M; FLEURY H; LENG B
      OXIDATIVE STRESS AND HIV-INFECTION - PREC ISIONS ON A CONCEPT AND A NEW THERAPEUTIC APPROACH

      Annales de medecine interne
    38. COUZIGOU P; DUMAS F; PELLEGRIN I; CHECKOURY G; TRIMOULET P; FONCK M; FLEURY H
      NO EVIDENCE FOR SEXUAL TRANSMISSION OF HEPATITIS-C VIRUS (A STUDY OF 61 COUPLES)

      Gastroenterology
    39. CONSTANS J; PELLEGRIN JL; PEUCHANT E; DUMON MF; PELLEGRIN I; SERGEANT C; SIMONOFF M; BROSSARD G; BARBEAU P; FLEURY H; CLERC M; LENG B; CONRI C
      PLASMA-LIPIDS IN HIV-INFECTED PATIENTS - A PROSPECTIVE-STUDY IN 95 PATIENTS

      European journal of clinical investigation
    40. CONSTANS J; PELLEGRIN JL; PEUCHANT E; THOMAS MF; DUMON MF; SERGEANT C; SIMONOFF M; PELLEGRIN I; BROSSARD G; BARBEAU P; CLERC M; FLEURY H; LENG B; CONRI C
      MEMBRANE FATTY-ACIDS AND SERUM ANTIOXIDAN TS IN 77 HIV PATIENTS

      La Revue de medecine interne
    41. CONSTANS J; PELLEGRIN JL; PELLEGRIN I; PEUCHANT E; DUMON MF; SERGEANT C; SIMONOFF M; BROSSARD G; BARBEAU P; CLERC M; FLEURY H; LENG B; CONRI C
      SERUM LEVELS OF INTERFERON AND TUMOR-NECR OSIS-FACTOR IN 95 HIV PATIENTS

      La Revue de medecine interne
    42. MASQUELIER B; LEMOIGNE E; PELLEGRIN I; DOUARD D; SANDLER B; FLEURY HJA
      PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HIV

      The New England journal of medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 06:32:20